Medical Cannabis and Anxiety in 2026: What Patients Need to Know Before Treatment
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AnxietyMental HealthResearchSafetyCBDTHCDosing Why This Matters Clinicians need current evidence on cannabis efficacy and…
Cannabinoid-Based Therapies Linked to Reduced Agitation in Alzheimer’s Patients, Meta …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingMental HealthCBDTHCSafety Why This Matters Clinicians treating Alzheimer’s disease patients…
Michigan universities can’t study dispensary pot on campus. MSU went mobile
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicySafetyMental HealthNeurologyAnxietyIndustry Why This Matters Michigan’s restriction on campus…
Cannabinoid-Based Therapies Linked to Reduced Agitation in Alzheimer’s Patients, Meta …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingMental HealthCBDTHCSafety Why This Matters Clinicians treating Alzheimer’s disease patients…
Medicinal Cannabis Matters: Friday Roundup – 19 June 2026
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainAnxietyMental HealthResearchPolicySafetyDosing Dr. Caplan’s Take I appreciate patient narratives, but a single…
CBD and Cardiovascular Recovery: HRV, Blood Pressure – Dr. Damas Cannabis
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDResearchSafetyAnxietyAgingDosingPolicy Why This Matters Clinicians should be cautious about recommending CBD for…
Anandamide – Chemical of Blissfulness
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyMental HealthCBDTHCAnxietySleep Clinical Summary I cannot generate a meaningful clinical summary from…
Summer Bud Guide
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. IndustryTHCCBDSafetyDosingResearchPolicy Why This Matters Clinicians should understand that patients increasingly make…
Clinical Trial: High Doses of CBD Superior to Placebo in Treating Neuropathic Pain
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDPainResearchNeurologyDosingSafetyPolicy Why This Matters This trial provides clinicians with evidence-based dosing…
PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyCBDDosingHempIndustry Why This Matters This Phase 3 trial represents progress toward a…